CN114917779B - A liquid vegetable oil matrix capillary suspension plastic fat and its construction method - Google Patents
A liquid vegetable oil matrix capillary suspension plastic fat and its construction method Download PDFInfo
- Publication number
- CN114917779B CN114917779B CN202210365661.9A CN202210365661A CN114917779B CN 114917779 B CN114917779 B CN 114917779B CN 202210365661 A CN202210365661 A CN 202210365661A CN 114917779 B CN114917779 B CN 114917779B
- Authority
- CN
- China
- Prior art keywords
- plastic fat
- capillary
- taking
- zein
- capillary suspension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920003023 plastic Polymers 0.000 title claims abstract description 37
- 239000000725 suspension Substances 0.000 title claims abstract description 30
- 239000007788 liquid Substances 0.000 title claims abstract description 21
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 14
- 239000008158 vegetable oil Substances 0.000 title claims abstract description 14
- 238000010276 construction Methods 0.000 title claims abstract description 5
- 239000011159 matrix material Substances 0.000 title claims description 9
- 239000012530 fluid Substances 0.000 claims abstract description 45
- 239000002245 particle Substances 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000003921 oil Substances 0.000 claims abstract description 11
- 235000019198 oils Nutrition 0.000 claims abstract description 11
- 239000012071 phase Substances 0.000 claims abstract description 5
- 239000007790 solid phase Substances 0.000 claims abstract description 4
- 229920002494 Zein Polymers 0.000 claims description 15
- 239000005019 zein Substances 0.000 claims description 15
- 229940093612 zein Drugs 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 12
- 239000008367 deionised water Substances 0.000 claims description 11
- 229910021641 deionized water Inorganic materials 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- 108010064851 Plant Proteins Proteins 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 235000021118 plant-derived protein Nutrition 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims 2
- 235000020238 sunflower seed Nutrition 0.000 claims 2
- 235000013305 food Nutrition 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000003925 fat Substances 0.000 description 30
- 235000019197 fats Nutrition 0.000 description 30
- 235000019486 Sunflower oil Nutrition 0.000 description 9
- 239000002600 sunflower oil Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 235000021003 saturated fats Nutrition 0.000 description 5
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000021083 high saturated fats Nutrition 0.000 description 2
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003627 anti-cholesterol Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Edible Oils And Fats (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
技术领域Technical Field
本发明公开涉及液体植物油技术领域,尤其涉及一种液体植物油基质毛细悬浮液塑性脂肪及其构建方法。The invention relates to the technical field of liquid vegetable oil, and in particular to a liquid vegetable oil matrix capillary suspension plastic fat and a construction method thereof.
背景技术Background Art
传统的塑性脂肪是依靠高熔点的脂类结晶包裹液体油而成,原料包括动、植物油脂或油脂氢化、分提产物等,经过这些过程的产品会含有反式脂肪酸和且饱和脂肪含量高,提高肥胖、心血管疾病、中风等慢性疾病的患病风险。我国是塑性脂肪消费大国,尤其儿童、青少年是塑性脂肪消费的主力人群,反式酸和过高含量饱和脂肪将会给儿童、青少年带来更加健康方面的危害。故研制出一种饱和脂肪含量低、必需脂肪酸含量高的塑性脂肪是当下应当解决的问题。Traditional plastic fats are made by wrapping liquid oil with high-melting-point lipid crystals. The raw materials include animal and vegetable oils or oil hydrogenation and fractionation products. Products that go through these processes will contain trans fatty acids and high saturated fat content, which increases the risk of chronic diseases such as obesity, cardiovascular disease, and stroke. my country is a major consumer of plastic fats, especially children and adolescents, who are the main consumers of plastic fats. Trans acids and excessive saturated fats will bring more health hazards to children and adolescents. Therefore, developing a plastic fat with low saturated fat content and high essential fatty acid content is a problem that should be solved now.
目前的解决方法主要有三种:①通过采用特殊的氢化过程(超临界氢化技术、超声波氢化技术等)来减少反式脂肪酸的产生,但是成本高,耗时费力,过程也复杂。②通过酯替代法来解决饱和脂肪含量高的问题,主要是酶催化酯交换,用单甘酯替代饱和脂肪或采用甘二酯结晶替代高熔点脂肪结晶,但是这种方法同样有成本高,过程复杂,耗时费力等问题。③制备成油凝胶替代塑性脂肪,主要是选用L-抗坏血酸和小分子乳化剂等为凝胶因子,用液体植物油来制备油凝胶,是一种有效的解决途径,但是获得的产品的流变学的可调节性差。There are three main solutions at present: ① Reduce the production of trans fatty acids by adopting special hydrogenation processes (supercritical hydrogenation technology, ultrasonic hydrogenation technology, etc.), but the cost is high, time-consuming and labor-intensive, and the process is also complicated. ② Solve the problem of high saturated fat content by ester substitution, mainly enzyme-catalyzed ester exchange, replace saturated fat with monoglyceride or replace high-melting point fat crystals with diglyceride crystals, but this method also has high cost, complex process, time-consuming and labor-intensive problems. ③ Prepare oil gel to replace plastic fat, mainly using L-ascorbic acid and small molecule emulsifiers as gel factors, and use liquid vegetable oil to prepare oil gel, which is an effective solution, but the rheological adjustability of the obtained product is poor.
综上,在食品领域开发一种新型塑性脂肪的制备方法是人们亟待要解决的问题。In summary, developing a new method for preparing plastic fat in the food field is an urgent problem to be solved.
发明内容Summary of the invention
鉴于此,本发明公开提供了一种液体植物油基质毛细悬浮液塑性脂肪的构建方法,得到的塑性脂肪与传统塑性脂肪的形态及流变学性质均高度相似,解决了传统塑性脂肪反式脂肪酸和饱和脂肪含量高等问题;In view of this, the present invention discloses a method for constructing a liquid vegetable oil matrix capillary suspension plastic fat, wherein the obtained plastic fat has a morphology and rheological properties highly similar to those of traditional plastic fats, and solves the problems of high trans fatty acid and saturated fat content in traditional plastic fats;
本发明提供的技术方案,具体为,一种液体植物油基质毛细悬浮液塑性脂肪的构建方法,包括:以毛细悬浮液状态为结构模型,选取植物蛋白颗粒为固相,液态油为主流体,水相为二次流体,构建得到毛细悬浮液塑性脂肪。The technical solution provided by the present invention is specifically a method for constructing a liquid vegetable oil matrix capillary suspension plastic fat, comprising: taking a capillary suspension state as a structural model, selecting plant protein particles as a solid phase, liquid oil as a main fluid, and an aqueous phase as a secondary fluid to construct a capillary suspension plastic fat.
优选地,具体包括如下步骤:Preferably, the method specifically comprises the following steps:
步骤1:选择原料:将一级葵花籽油作为一次流体,去离子水作为二次流体,优先被一次流体润湿的玉米醇溶蛋白作为固体颗粒;Step 1: Select raw materials: use primary sunflower oil as the primary fluid, deionized water as the secondary fluid, and zein preferentially wetted by the primary fluid as the solid particles;
步骤2:将玉米醇溶蛋白粉碎后过100目标准筛,备用;Step 2: Grind the zein and pass it through a 100-mesh standard sieve for later use;
步骤3:取质量百分含量占比为20%-30%过筛后的玉米醇溶蛋白颗粒分散到所述一级葵花籽油中,搅拌1.5min,搅拌速率为:1200-1500rpm。Step 3: Take 20%-30% of the sieved zein particles by mass and disperse them into the first-grade sunflower oil, and stir for 1.5 minutes at a stirring rate of 1200-1500 rpm.
步骤4:向步骤3得到的混合溶液中,继续加入质量百分占比为1%-5%的去离子水,继续搅拌1min,搅拌速率为:1200-1500rpm,最终得到所述塑性脂肪。Step 4: Add 1%-5% by mass of deionized water to the mixed solution obtained in step 3, and continue stirring for 1 min at a stirring rate of 1200-1500 rpm to finally obtain the plastic fat.
优选地,所述玉米醇溶蛋白颗粒的质量百分含量占比为20%,去离子水的质量百分含量占比为5%。Preferably, the mass percentage of the zein particles is 20%, and the mass percentage of deionized water is 5%.
本发明还提供了一种液体植物油基质毛细悬浮液塑性脂肪,由上述方法制备。The invention also provides a liquid vegetable oil matrix capillary suspension plastic fat, which is prepared by the above method.
本发明提供的一种液体植物油基质毛细悬浮液塑性脂肪及其构建方法,对比其他可替代传统塑性脂肪的方法,解决了传统方法的成本高、耗时费力、过程复杂等问题,本发明中毛细悬浮液制备简单,材料绿色安全,适合大规模工业化生产,在食品领域、制药行业、护肤品生产领域都将有广阔的应用空间,具备多方面效益。The present invention provides a liquid vegetable oil matrix capillary suspension plastic fat and a construction method thereof. Compared with other methods that can replace traditional plastic fats, the present invention solves the problems of high cost, time and labor consumption, and complex process of traditional methods. The capillary suspension in the present invention is simple to prepare, the material is green and safe, and it is suitable for large-scale industrial production. It will have broad application space in the food field, pharmaceutical industry, and skin care product production field, and has many benefits.
应当理解的是,以上的一般描述和后文的细节描述仅是示例性和解释性的,并不能限制本发明的公开。It is to be understood that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the present disclosure.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为本发明中主流体与二次相的比例不同时的毛细悬浮液的外观形态照片;FIG1 is a photograph of the appearance of a capillary suspension when the ratio of the primary fluid to the secondary phase is different in the present invention;
图2为本发明实施1-2中得到的不同二次流体比例条件下的毛细悬浮液塑性脂肪微观结构示意图;其中图a中颗粒质量分数:20%,二次流体比例:0%;图b中颗粒质量分数:20%,二次流体比例:1%;图c中颗粒质量分数:20%,二次流体比例:3%;FIG2 is a schematic diagram of the microstructure of the plastic fat of the capillary suspension under different secondary fluid ratios obtained in Embodiment 1-2 of the present invention; wherein in FIGa, the particle mass fraction is 20%, and the secondary fluid ratio is 0%; in FIGb, the particle mass fraction is 20%, and the secondary fluid ratio is 1%; in FIGc, the particle mass fraction is 20%, and the secondary fluid ratio is 3%;
图d中颗粒质量分数:20%,二次流体比例:5%;图e中颗粒质量分数:30%,二次流体比例:0%;图f中颗粒质量分数:30%,二次流体比例:1%;图g中颗粒质量分数:30%,二次流体比例:3%;图h中颗粒质量分数:30%,二次流体比例:5%。In Figure d, the particle mass fraction is 20%, and the secondary fluid ratio is 5%; in Figure e, the particle mass fraction is 30%, and the secondary fluid ratio is 0%; in Figure f, the particle mass fraction is 30%, and the secondary fluid ratio is 1%; in Figure g, the particle mass fraction is 30%, and the secondary fluid ratio is 3%; in Figure h, the particle mass fraction is 30%, and the secondary fluid ratio is 5%.
具体实施方式DETAILED DESCRIPTION
这里将详细地对示例性实施例进行说明。以下示例性实施例中所描述的实施方式并不代表与本发明相一致的所有实施方式。相反,它们仅是与如所附权利要求书中所详述的、本发明的一些方面相一致的系统的例子。Here, exemplary embodiments are described in detail. The embodiments described in the following exemplary embodiments do not represent all embodiments consistent with the present invention. Instead, they are only examples of systems consistent with some aspects of the present invention as detailed in the appended claims.
为解决传统塑性脂肪反式脂肪酸和饱和脂肪含量高等问题,本实施方案提供了一种液体植物油基质毛细悬浮液塑性脂肪的构建方法,包括:以毛细状态为结构模型,选取植物蛋白颗粒为固相,液态油为主流体,水相为二次流体,构建得到毛细悬液塑性脂肪。In order to solve the problems of high trans fatty acid and saturated fat content in traditional plastic fats, the present embodiment provides a method for constructing a liquid vegetable oil matrix capillary suspension plastic fat, including: taking the capillary state as the structural model, selecting plant protein particles as the solid phase, liquid oil as the main fluid, and the water phase as the secondary fluid to construct a capillary suspension plastic fat.
本发明以毛细悬浮液为结构模型构建毛细悬液塑性脂肪替代传统塑性脂肪,毛细悬浮液是两种不互溶的流体与一种对于两种液相湿润程度不同的固体颗粒形成的混合系,毛细悬浮液被分为两种不同的状态:二次流体优先润湿颗粒的钟摆状态;二次流体对颗粒的润湿性不如一次流体的毛细状态。本发明中以毛细状态为结构模板,固体颗粒在毛细液桥连接下形成网络结构,使液体变成半固体状态。以液态油为主流体、水相为二次流体的毛细悬浮液与传统塑性脂肪的形态及流变学性质均高度相似。The present invention uses a capillary suspension as a structural model to construct a capillary suspension plastic fat to replace traditional plastic fat. The capillary suspension is a mixed system formed by two immiscible fluids and a solid particle with different wettability to the two liquid phases. The capillary suspension is divided into two different states: a pendulum state in which the secondary fluid preferentially wets the particles; and a capillary state in which the wettability of the secondary fluid to the particles is not as good as that of the primary fluid. In the present invention, the capillary state is used as a structural template, and the solid particles form a network structure under the connection of the capillary liquid bridge, so that the liquid becomes a semi-solid state. The capillary suspension with liquid oil as the main fluid and the water phase as the secondary fluid is highly similar to the morphology and rheological properties of traditional plastic fat.
优选地,具体包括如下步骤:Preferably, the method specifically comprises the following steps:
步骤1:选择原料:将一级葵花籽油作为一次流体,去离子水作为二次流体,优先被一次流体润湿的玉米醇溶蛋白作为固体颗粒;本发明以一级葵花籽油作为基料,葵花籽油中的不饱和脂肪酸含量达90%以上,并且富含亚油酸以及维生素A、B、D、E,有助于促进组织代谢和生长发育。葵花籽油中还含有α-生育酚、角鲨烯、甾醇类等物质,这几类物质都具有良好的抗氧化能力,能够抑制食用油在储存过程中的氧化进程,还具有抗肿瘤和降低胆固醇等生理功能。Step 1: Selecting raw materials: using first-grade sunflower oil as a primary fluid, deionized water as a secondary fluid, and zein preferentially wetted by the primary fluid as solid particles; the present invention uses first-grade sunflower oil as a base material, the unsaturated fatty acid content in the sunflower oil is more than 90%, and it is rich in linoleic acid and vitamins A, B, D, and E, which helps to promote tissue metabolism and growth and development. Sunflower oil also contains substances such as α-tocopherol, squalene, and sterols, all of which have good antioxidant capacity, can inhibit the oxidation process of edible oil during storage, and also have physiological functions such as anti-tumor and cholesterol reduction.
步骤2:将玉米醇溶蛋白粉碎后过100目标准筛,备用;Step 2: Grind the zein and pass it through a 100-mesh standard sieve for later use;
步骤3:取质量百分含量占比为20%-30%过筛后的玉米醇溶蛋白颗粒分散到所述一级葵花籽油中,搅拌1.5min,搅拌速率为:1200-1500rpm。Step 3: Take 20%-30% of the sieved zein particles by mass and disperse them into the first-grade sunflower oil, and stir for 1.5 minutes at a stirring rate of 1200-1500 rpm.
步骤4:向步骤3得到的混合溶液中,继续加入质量百分占比为1%-5%的去离子水,继续搅拌1min,搅拌速率为:1200-1500rpm,最终得到所述塑性脂肪。Step 4: Add 1%-5% by mass of deionized water to the mixed solution obtained in step 3, and continue stirring for 1 min at a stirring rate of 1200-1500 rpm to finally obtain the plastic fat.
优选地,所述玉米醇溶蛋白颗粒的质量百分含量占比为20%,去离子水的质量百分含量占比为5%。Preferably, the mass percentage of the zein particles is 20%, and the mass percentage of deionized water is 5%.
下面结合具体的实施例对本发明进行更近一步的解释说明,但是并不用于限制本发明的保护范围。The present invention is further explained below in conjunction with specific embodiments, but is not intended to limit the protection scope of the present invention.
实施例1Example 1
取四份20%(ω)过筛后的玉米醇溶蛋白颗粒分别分散到葵花籽油中,用榨汁机搅拌1.5min,再分别加入0%、1%、3%、5%(ω)的去离子水,再用榨汁机转速1500rpm搅拌1min,即得不同比例二次流体、蛋白颗粒质量分数为20%的毛细悬浮液塑性脂肪。Four portions of 20% (ω) sieved zein particles were dispersed in sunflower oil respectively, stirred with a juicer for 1.5 min, and then 0%, 1%, 3%, and 5% (ω) deionized water were added respectively, and then stirred with a juicer at a speed of 1500 rpm for 1 min to obtain capillary suspension plastic fats with different proportions of secondary fluids and a protein particle mass fraction of 20%.
实施例2Example 2
取四份30%(ω)过筛后的玉米醇溶蛋白颗粒分别分散到葵花籽油中,用榨汁机搅拌1.5min,再分别加入0%、1%、3%、5%(ω)的去离子水,再用榨汁机转速1500rpm搅拌1min,即得不同比例二次流体、蛋白颗粒质量分数为30%的毛细悬浮液塑性脂肪。Four portions of 30% (ω) sieved zein particles were dispersed in sunflower oil respectively, stirred with a juicer for 1.5 min, and then 0%, 1%, 3%, and 5% (ω) deionized water were added respectively, and then stirred with a juicer at a speed of 1500 rpm for 1 min to obtain capillary suspension plastic fat with different proportions of secondary fluid and a protein particle mass fraction of 30%.
将实施例1-2制得的毛细悬浮液塑性脂肪进行外观观察,结果图1所示。将实施例1-2制得的毛细悬浮液塑性脂肪进行微观结构观察,结果图2所示。The appearance of the capillary suspension plastic fat prepared in Example 1-2 was observed, and the result is shown in Figure 1. The microstructure of the capillary suspension plastic fat prepared in Example 1-2 was observed, and the result is shown in Figure 2.
由以上结构可知,在蛋白颗粒质量分数为20%时,二次流体比例为0%、1%、3%时,外观形态为流体状态,呈现流动性,而为5%时,外观形态则为明显的凝胶状态,呈现半固体性。在图2的微观结构角度观察,二次流体比例为0%时,没有毛细管桥网络结构,为1%和3%时,有少量的毛细管桥网络结构,并且二次流体比例为3%时,毛细管桥网络结构明显多于二次流体比例为3%时,而为5%时,可以观察到大量的毛细管桥网络结构几乎布满整个显微镜视野。From the above structure, it can be seen that when the mass fraction of protein particles is 20%, when the proportion of secondary fluid is 0%, 1%, and 3%, the appearance is in a fluid state, showing fluidity, while when it is 5%, the appearance is an obvious gel state, showing semi-solidity. From the microscopic structure perspective of Figure 2, when the proportion of secondary fluid is 0%, there is no capillary bridge network structure, when it is 1% and 3%, there is a small amount of capillary bridge network structure, and when the proportion of secondary fluid is 3%, the capillary bridge network structure is significantly more than when the proportion of secondary fluid is 3%, and when it is 5%, a large number of capillary bridge network structures can be observed that almost cover the entire microscope field of view.
在蛋白颗粒质量分数为30%时,二次流体比例为0%、1%时,外观形态为流体状态,呈现流动性,而为3%、5%时,外观形态则为明显的凝胶状态,呈现半固体性。在微观结构角度观察,二次流体比例为0%、1%时,几乎没有毛细管桥网络结构,为3%时,可以观察到很多毛细管桥网络结构,而为5%时,不仅可以观察到毛细管桥网络结构,还出现了颗粒聚集现象,这点在外观形态上也有体现。When the protein particle mass fraction is 30%, the secondary fluid ratio is 0% and 1%, and the appearance is in a fluid state, showing fluidity, while at 3% and 5%, the appearance is an obvious gel state, showing semi-solidity. From the perspective of microstructure, when the secondary fluid ratio is 0% and 1%, there is almost no capillary bridge network structure, when it is 3%, many capillary bridge network structures can be observed, and when it is 5%, not only can the capillary bridge network structure be observed, but also particle aggregation phenomenon occurs, which is also reflected in the appearance.
综上所述,可以得出,毛细管悬浮液中的毛细管桥网络结构数量与颗粒质量分数和二次流体比例有关,并且在一般情况下成正比,但是当颗粒质量分数和二次流体比例过大时,容易出现蛋白颗粒聚集现象。In summary, it can be concluded that the number of capillary bridge network structures in capillary suspensions is related to the particle mass fraction and the secondary fluid ratio, and is generally proportional. However, when the particle mass fraction and the secondary fluid ratio are too large, protein particle aggregation is likely to occur.
本领域技术人员在考虑说明书及实践这里公开的发明后,将容易想到本发明的其它实施方案。本申请旨在涵盖本发明的任何变型、用途或者适应性变化,这些变型、用途或者适应性变化遵循本发明的一般性原理并包括本发明未公开的本技术领域中的公知常识或惯用技术手段。说明书和实施例仅被视为示例性的,本发明的真正范围和精神由权利要求指出。Those skilled in the art will readily appreciate other embodiments of the present invention after considering the specification and practicing the invention disclosed herein. This application is intended to cover any variations, uses or adaptations of the present invention that follow the general principles of the present invention and include common knowledge or customary techniques in the art that are not disclosed by the present invention. The specification and examples are to be considered exemplary only, and the true scope and spirit of the present invention are indicated by the claims.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210365661.9A CN114917779B (en) | 2022-04-08 | 2022-04-08 | A liquid vegetable oil matrix capillary suspension plastic fat and its construction method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210365661.9A CN114917779B (en) | 2022-04-08 | 2022-04-08 | A liquid vegetable oil matrix capillary suspension plastic fat and its construction method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114917779A CN114917779A (en) | 2022-08-19 |
| CN114917779B true CN114917779B (en) | 2024-08-16 |
Family
ID=82805428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210365661.9A Active CN114917779B (en) | 2022-04-08 | 2022-04-08 | A liquid vegetable oil matrix capillary suspension plastic fat and its construction method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114917779B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114158733A (en) * | 2022-02-11 | 2022-03-11 | 仙乐健康科技股份有限公司 | Oil gel and preparation method and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5021248A (en) * | 1988-09-19 | 1991-06-04 | Enzytech, Inc. | Hydrophobic protein microparticles and preparation thereof |
| WO2011023405A1 (en) * | 2009-08-28 | 2011-03-03 | Georgia Tech Research Corporation | Method and electro-fluidic device to produce emulsions and particle suspensions |
| US10934191B2 (en) * | 2015-09-04 | 2021-03-02 | Georgia Tech Research Corporation | Capillary foams, methods of making thereof, and uses thereof including for mitigation of oil spills |
| CN113017095B (en) * | 2021-03-15 | 2023-01-24 | 南京财经大学 | Preparation method and application of corn oil quinoa protein Pickering high internal phase emulsion |
| CN113100298A (en) * | 2021-05-18 | 2021-07-13 | 四川大学 | A kind of preparation method of oil gel for replacing hydrogenated vegetable oil |
| CN114190443A (en) * | 2021-11-17 | 2022-03-18 | 华南理工大学 | Method for preparing oleogel from protein gel |
-
2022
- 2022-04-08 CN CN202210365661.9A patent/CN114917779B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114158733A (en) * | 2022-02-11 | 2022-03-11 | 仙乐健康科技股份有限公司 | Oil gel and preparation method and use thereof |
Non-Patent Citations (1)
| Title |
|---|
| 毛细管悬浮液的研究进展;王丽娟、李宏漫、李慧等;《沈阳师范大学学报(自然科学版)》;20211231;第39卷(第6期);第561-565页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114917779A (en) | 2022-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Edible oleogels as solid fat alternatives: Composition and oleogelation mechanism implications | |
| Silva et al. | Oleogels as a fat substitute in food: A current review | |
| Siraj et al. | Organogelators as a saturated fat replacer for structuring edible oils | |
| Dassanayake et al. | Formation of oleogels based on edible lipid materials | |
| CN103283866B (en) | camellia oil microemulsion and preparation method thereof | |
| CN115363102B (en) | O/W, W/O, bicontinuous three-phase-change adjustable fat analogue, preparation method and application | |
| CN112868816A (en) | Preparation method of water-in-oil emulsion gel based on diglyceride solid lipid nanoparticles | |
| Marangoni et al. | An overview of the past, present, and future of organogels | |
| CN110089694B (en) | A kind of egg yolk-phytosterol-polysaccharide composite emulsion gel and preparation method thereof | |
| CN103054030A (en) | Method for preparing perilla oil powder through microencapsulation | |
| Patel | Oil structuring: concepts, overview and future perspectives | |
| CN103238675A (en) | A kind of preparation method of Camellia oleifera seed oil linseed oil compound microcapsule | |
| CN114304283A (en) | Preparation method of food-grade double gel based on grease gel and hydrogel | |
| CN103404854A (en) | Preparation method of phytosterol ester microcapsules | |
| CN103815050A (en) | Sweet cream and its preparation method | |
| Zampouni et al. | On the structural and mechanical properties of mixed coconut and olive oil oleogels and bigels | |
| CN114847359A (en) | Microcapsule type fat powder for diabetes food and preparation method and application thereof | |
| CN114747653A (en) | Fat simulant with vegetable protein and citrus fiber as matrix and application thereof in vegetable protein meat | |
| CN101326941A (en) | A kind of preparation method of low/zero trans fatty acid margarine/shortening base oil | |
| CN106900881A (en) | Fat or oil composition of Water-In-Oil bag oil and preparation method thereof | |
| CN115349556A (en) | Vegetable meat substitute fat based on peanut oil body and preparation method and application thereof | |
| CN108142950A (en) | A kind of acer truncatum seed oil composite Nano microcapsule powder for improving brain neuroblastoma and preparation method thereof | |
| CN110179119A (en) | The DHA algal oil microcapsule powder and preparation method thereof of buttermilk embedding | |
| CN106490189A (en) | A kind of margarine and preparation method thereof | |
| Fallahasgari et al. | An overview focusing on modification of margarine rheological and textural properties for improving physical quality |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |